PURPL and cancer: Compared to patients with low expression of PURPL, patients with high expression of PURPL showed shorter recurrence free survival (RFS) time and overall survival (OS) time, which was queried in Kaplan-Meier Plotter Pan-Cancer database including 374 ovarian cancer patients (Figure 3).